These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 22454448

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Firm- and drug-specific patterns of generic drug payments by US medicaid programs: 1991-2008.
    Kelton CM, Chang LV, Guo JJ, Yu Y, Berry EA, Bian B, Heaton PC.
    Appl Health Econ Health Policy; 2014 Apr; 12(2):165-77. PubMed ID: 24550087
    [Abstract] [Full Text] [Related]

  • 6. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
    LaVange LM, Silverman HA.
    Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
    [Abstract] [Full Text] [Related]

  • 7. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM, Rebelein RP, Heaton PC, Ferrand Y, Guo JJ.
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Utilization, spending, and price trends for short- and long-acting Beta-agonists and inhaled corticosteroids in the medicaid program, 1991-2010.
    Chiu SF, Kelton CM, Guo JJ, Wigle PR, Lin AC, Szeinbach SL.
    Am Health Drug Benefits; 2011 May; 4(3):140-9. PubMed ID: 25126346
    [Abstract] [Full Text] [Related]

  • 10. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS, Miller GE.
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [Abstract] [Full Text] [Related]

  • 11. Spending, Utilization, and Price Trends for Immune Checkpoint Inhibitors in US Medicaid Programs: An Empirical Analysis from 2011 to 2021.
    Shin YE, Kumar A, Guo JJ.
    Clin Drug Investig; 2023 Apr; 43(4):289-298. PubMed ID: 37005969
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years' Experience 1991-2015.
    Almalki ZS, Yue X, Xia Y, Wigle PR, Guo JJ.
    Pharmacoecon Open; 2017 Jun; 1(2):123-131. PubMed ID: 29442334
    [Abstract] [Full Text] [Related]

  • 14. Prescription analgesic and antidepressant utilization and cost among elderly Medicaid beneficiaries before and after nursing home admission.
    Chu L, Schnelle JF, Osterweil D.
    J Am Med Dir Assoc; 2004 Jun; 5(2):75-81. PubMed ID: 14984617
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. ACE Inhibitor and ARB utilization and expenditures in the Medicaid fee-for-service program from 1991 to 2008.
    Bian B, Kelton CM, Guo JJ, Wigle PR.
    J Manag Care Pharm; 2010 Jun; 16(9):671-9. PubMed ID: 21067253
    [Abstract] [Full Text] [Related]

  • 17. Utilization, Spending, and Price of Opioid Medications in the US Medicaid Programs Between 1991 and 2019.
    Alsultan MM, Guo JJ.
    Am Health Drug Benefits; 2022 Mar; 15(1):31-37. PubMed ID: 35586617
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.